The FDA has just approved a new drug called Donanemab that helps slow down the progression of Alzheimer's disease.
This is really exciting news because it's the second drug that can actually fight the disease itself, not just manage the symptoms.
Donanemab works by targeting a protein called amyloid that builds up in the brains of people with Alzheimer's, causing memory loss and other problems.
While it's not a cure, Donanemab gives people with Alzheimer's and their families more time together and a chance to live better lives.
